Peterson V E, Crapo P A, Weininger J, Ginsberg H, Olefsky J
Am J Clin Nutr. 1975 Jun;28(6):584-7. doi: 10.1093/ajcn/28.6.584.
In order to assess the possible effects of ascorbic acid on plasma cholesterol and triglyceride levels and plasma lipoprotein composition, nine hypercholesterolemic subjects were treated with oral ascorbic acid (4 g/day) for 2 months. The data demonstrate: 1) no significant change in plasma cholesterol or triglyceride levels; 2) no significant change in the cholesterol or triglyceride concentrations of the major lipoprotein classes; and 3) the unexpected appearance of extra pre-beta bands on lipoprotein electrophoresis by the end of the ascorbic acid treatment period.
为了评估抗坏血酸对血浆胆固醇和甘油三酯水平以及血浆脂蛋白组成的可能影响,9名高胆固醇血症患者接受了口服抗坏血酸(4克/天)治疗,为期2个月。数据表明:1)血浆胆固醇或甘油三酯水平无显著变化;2)主要脂蛋白类别的胆固醇或甘油三酯浓度无显著变化;3)在抗坏血酸治疗期结束时,脂蛋白电泳意外出现额外的前β带。